These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

924 related articles for article (PubMed ID: 18202440)

  • 41. Virulotyping of Shigella spp. isolated from pediatric patients in Tehran, Iran.
    Ranjbar R; Bolandian M; Behzadi P
    Acta Microbiol Immunol Hung; 2017 Mar; 64(1):71-80. PubMed ID: 28218003
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Shigella effector IpaH4.5 targets 19S regulatory particle subunit RPN13 in the 26S proteasome to dampen cytotoxic T lymphocyte activation.
    Otsubo R; Mimuro H; Ashida H; Hamazaki J; Murata S; Sasakawa C
    Cell Microbiol; 2019 Mar; 21(3):e12974. PubMed ID: 30414351
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel inhibitors that target bacterial virulence identified via HTS against intra-macrophage survival of
    Miljkovic M; Lozano S; Castellote I; de Cózar C; Villegas-Moreno AI; Gamallo P; Jimenez-Alfaro Martinez D; Fernández-Álvaro E; Ballell L; Garcia GA
    mSphere; 2023 Oct; 8(5):e0015423. PubMed ID: 37565760
    [No Abstract]   [Full Text] [Related]  

  • 44. Two msbB genes encoding maximal acylation of lipid A are required for invasive Shigella flexneri to mediate inflammatory rupture and destruction of the intestinal epithelium.
    D'Hauteville H; Khan S; Maskell DJ; Kussak A; Weintraub A; Mathison J; Ulevitch RJ; Wuscher N; Parsot C; Sansonetti PJ
    J Immunol; 2002 May; 168(10):5240-51. PubMed ID: 11994481
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Virulence-related genes are associated with clinical and nutritional outcomes of Shigella/Enteroinvasive Escherichia coli pathotype infection in children from Brazilian semiarid region: A community case-control study.
    Bona M; Medeiros PH; Santos AK; Freitas T; Prata M; Veras H; Amaral M; Oliveira D; Havt A; Lima AÂ
    Int J Med Microbiol; 2019 Mar; 309(2):151-158. PubMed ID: 30733116
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationship among Shigella spp. and enteroinvasive Escherichia coli (EIEC) and their differentiation.
    Ud-Din A; Wahid S
    Braz J Microbiol; 2014; 45(4):1131-8. PubMed ID: 25763015
    [TBL] [Abstract][Full Text] [Related]  

  • 47. How Shigella Utilizes Ca(2+) Jagged Edge Signals during Invasion of Epithelial Cells.
    Bonnet M; Tran Van Nhieu G
    Front Cell Infect Microbiol; 2016; 6():16. PubMed ID: 26904514
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Virulence gene profiles of
    Sethuvel DPM; Anandan S; Michael JS; Murugan D; Neeravi A; Verghese VP; Walia K; Veeraraghavan B
    Pathog Glob Health; 2019 Jun; 113(4):173-179. PubMed ID: 31221039
    [No Abstract]   [Full Text] [Related]  

  • 49. Manipulation of epithelial cell death pathways by Shigella.
    Thygesen SJ; Pliego-Zamora A; Stacey KJ
    EMBO J; 2020 Sep; 39(17):e106202. PubMed ID: 32869315
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A new piece of the Shigella Pathogenicity puzzle: spermidine accumulation by silencing of the speG gene [corrected].
    Barbagallo M; Di Martino ML; Marcocci L; Pietrangeli P; De Carolis E; Casalino M; Colonna B; Prosseda G
    PLoS One; 2011; 6(11):e27226. PubMed ID: 22102881
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The inside story of Shigella invasion of intestinal epithelial cells.
    Carayol N; Tran Van Nhieu G
    Cold Spring Harb Perspect Med; 2013 Oct; 3(10):a016717. PubMed ID: 24086068
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SepA Enhances
    Meza-Segura M; Birtley JR; Maldonado-Contreras A; Mueller C; Simin KJ; Stern LJ; McCormick BA
    mBio; 2021 Dec; 12(6):e0283321. PubMed ID: 34724811
    [No Abstract]   [Full Text] [Related]  

  • 53. Cellular Aspects of Shigella Pathogenesis: Focus on the Manipulation of Host Cell Processes.
    Killackey SA; Sorbara MT; Girardin SE
    Front Cell Infect Microbiol; 2016; 6():38. PubMed ID: 27066460
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Current aspects of Shigella pathogenesis.
    Torres AG
    Rev Latinoam Microbiol; 2004; 46(3-4):89-97. PubMed ID: 17061529
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diffusible signal factors (DSFs) bind and repress VirF, the leading virulence activator of Shigella flexneri.
    Trirocco R; Pasqua M; Tramonti A; Colonna B; Paiardini A; Prosseda G
    Sci Rep; 2023 Aug; 13(1):13170. PubMed ID: 37580399
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A human pathogenic bacterium Shigella proliferates in plants through adoption of type III effectors for shigellosis.
    Jo SH; Lee J; Park E; Kim DW; Lee DH; Ryu CM; Choi D; Park JM
    Plant Cell Environ; 2019 Nov; 42(11):2962-2978. PubMed ID: 31250458
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exploitation of host factors for efficient infection by Shigella.
    Adam T
    Int J Med Microbiol; 2001 Sep; 291(4):287-98. PubMed ID: 11680789
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High-Throughput Screening of Type III Secretion Determinants Reveals a Major Chaperone-Independent Pathway.
    Ernst NH; Reeves AZ; Ramseyer JE; Lesser CF
    mBio; 2018 Jun; 9(3):. PubMed ID: 29921672
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selection for Phage Resistance Reduces Virulence of Shigella flexneri.
    Kortright KE; Done RE; Chan BK; Souza V; Turner PE
    Appl Environ Microbiol; 2022 Jan; 88(2):e0151421. PubMed ID: 34788068
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Single-domain antibodies pinpoint potential targets within
    Barta ML; Shearer JP; Arizmendi O; Tremblay JM; Mehzabeen N; Zheng Q; Battaile KP; Lovell S; Tzipori S; Picking WD; Shoemaker CB; Picking WL
    J Biol Chem; 2017 Oct; 292(40):16677-16687. PubMed ID: 28842484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.